From: Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series
Outcome Rankin | p | Total | ||
---|---|---|---|---|
<2 | ≥2 | |||
N (%) | 51 (60) | 34 (40) | 85 | |
Age, mean (SD), y | 38.9 (14) | 49 (17.7) | 0.005 | 43 (16.2) |
Sex, male/female | 21/30 | 19/15 | 0.194 | 40/45 |
Follow up, median (IQR), y | 2.9 (1.5-4.1) | 2.7 (0.3-7.4) | 0.683 | 2.9 (1–4.8) |
Time to maximum deficit, mean (SD), d | 7.2 (7) | 6.91 (7.6) | 0.821 | 7.1 (7.1) |
Admission Rankin Mean (SD) | 2.27 (1) | 3.65 (1.1) | <0.001 a | 2.82 (1.2) |
Outcome Rankin Mean (SD) | ____ | ____ | ____ | 1.4 (1.3) |
Time onset-start treatment, mean (SD), d | 9.7 (8.3) | 8.5 (8) | 0.602 | 9.2 (8.1) |
Back pain, n (%) | 19 (37.3) | 16 (47.1) | 0.380 | 35 (41.2) |
Urinary sphincter dysfunction, n (%) | 21 (41.2) | 26 (76.5) | 0.001 a | 47 (55.3) |
Anal sphincter dysfunction, n (%) | 2 (4) | 9 (26.5) | 0.002 | 11 (13) |
Previous infection, n (%) | 19 (37.3) | 8 (23.5) | 0.237 | 27 (31.8) |
Summer season/Not summer season, n (%) | 9/49 (18) /40/49 (81.6) | 5/34 (14.7) / 29/34 (85.3) | 0.661 | 14 (16.47) /69 (81.17) |
TM relapses, n (%) | 5/51 (9.8) | 0/33 (0) | 0.085 | 5/84 (6) |
MS conversion, n (%) | 8 (15.7) | 3 (8.8) | 0.513 | 11 (13) |